Filing Details

Accession Number:
0001140361-13-047484
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-24 16:08:41
Reporting Period:
2013-12-21
Filing Date:
2013-12-24
Accepted Time:
2013-12-24 16:08:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1037760 Cepheid CPHD Laboratory Analytical Instruments (3826) 770441625
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1479659 Kerry Flom C/O Cepheid
904 Caribbean Drive
Sunnyvale CA 94089
Evp, Regulatory Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-21 10,000 $0.00 30,000 No 4 M Direct
Common Stock Disposition 2013-12-23 9,900 $46.50 20,100 No 4 S Direct
Common Stock Disposition 2013-12-23 100 $47.15 20,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2013-12-21 10,000 $0.00 10,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Vesting of restricted stock units ("RSUs") granted to the Reporting Person on December 21, 2009.
  2. The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 11, 2013.
  3. Represents the aggregate of sales effected on the same day at different prices.
  4. Represents the weighted average sales price per share. The shares sold at prices ranging from $46.0575 to $46.93 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  5. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  6. 50% of the RSUs vested on each two-year anniversary of the grant date.